Short Summary
M/S. Reata Pharmaceuticals challenged an order passed by the Controller of Patents, arguing that the authority failed to consider superior data regarding their improved product version. The court dismissed the writ petition, holding that since the impugned order was statutorily appealable, the petitioner must utilize the available statutory remedy.
Detailed Summary
Every founder dreams of the moment their breakthrough product earns a patent. But what happens when the patent office issues an unfavorable order, and the innovator decides to leapfrog the appeals process straight to the High Court? The case of M/S. Reata Pharmaceuticals versus the Union of India offers a sharp reminder: in IP disputes, choosing the wrong legal doorway can slam your case shut before the merits are ever heard. This story matters because it illustrates a foundational principle of patent litigation — the discipline of following the procedural path laid out by law.
M/S. Reata Pharmaceuticals, a company working on pharmaceutical innovation, found itself at odds with an order passed by the Controller of Patents. The petitioner believed that the Controller had failed to properly consider what they described as superior data relating to an improved version of their product. Convinced that the patent authority had overlooked critical evidence, Reata Pharmaceuticals chose to file a writ petition directly before the High Court, challenging the Controller's order and seeking relief against the Union of India and another respondent. The dispute centered on whether the patent authority had given due weight to the technical and scientific data Reata presented in support of its improved formulation.
Reata Pharmaceuticals argued that the Controller of Patents had erred by failing to consider the superior data they had submitted regarding their improved product version. From the petitioner's perspective, the patent authority's order was flawed because it did not properly evaluate the enhanced characteristics or benefits of the new formulation. On the other side, the respondents — the Union of India and the other party — countered that Reata had taken an impermissible shortcut. Their central argument was procedural: the petitioner had bypassed the statutorily prescribed remedy available to them. The legal friction was not really about the science of the improved product; it was about whether Reata had the right to invoke the writ jurisdiction of the High Court when a dedicated appellate mechanism already existed under the patent statute.
The court dismissed the writ petition. Its reasoning rested on a well-established principle of administrative and IP law: when an order is appealable under a statute, the aggrieved party must ordinarily pursue that statutory remedy rather than approach the High Court directly through a writ petition. The court held that the existence of a statutory alternative remedy is not an absolute bar to writ jurisdiction — but it becomes decisive unless the impugned order was passed without jurisdiction or was vitiated by a breach of the principles of natural justice. Since Reata did not establish either of those exceptional circumstances, the petition was dismissed, leaving the petitioner to pursue the appeal route provided by the patent law framework.
For founders, startup leaders, and IP professionals, the lesson is procedural but profound: always map out the full statutory appeal ladder before reaching for extraordinary remedies like writ petitions. A strong case on the merits can still be defeated by a weak choice of forum. If you believe a patent office has ignored your data or erred in its analysis, document your grievances carefully, but channel them through the designated appellate authority first. Reserve writ jurisdiction for situations where the lower authority truly lacked jurisdiction or violated natural justice — not as a convenient shortcut. Disciplined procedural strategy protects your substantive innovations from being lost on a technicality.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court (Appellete Side). Understanding the court's reasoning in M/S. Reata Pharmaceuticals vs Union Of India is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.